Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers
08/06/2021
/
Publications
/
Head and neck
Salivary Gland Cancer
Skin malignancies
skull base
Oropharyngeal Cancer
Reirradiation
Toxicity
In select clinical scenarios of well-lateralized tumors, radiotherapy can be delivered to the primary tumor or tumor bed and the ipsilateral nodal regions. This...
Proton Therapy for Major Salivary Gland Cancer: Clinical Outcomes
08/06/2021
/
Publications
/
Salivary Gland Cancer
Clinical Outcomes
PBT
Head and neck
Mucositis
Toxicity
A study by the MD Anderson group reported clinical outcomes of 72 patients with major salivary gland cancers (SGCs) treated by PBT. Sixty-three patients (88%)...
Minimal acute toxicity from proton beam therapy for major salivary gland cancer.
11/12/2019
/
Publications
/
Head and neck
Salivary Gland Cancer
Parotid Gland Cancer
Nausea
Mucositis
Xerostomia
Dysgeusia
This multicenter study reported acute toxicity outcomes of patients with major salivary gland cancers registered on the Proton Collaborative Group REG001-09...
A comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.
12/12/2021
/
Publications
/
IMPT
VMAT
Salivary Gland Cancer
Head and neck
A cohort of tonsil and salivary gland cancer patients who received ipsilateral curative-intent radiotherapy delivered by IMPT or VMAT were reviewed including...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.